Opinion: A New Global Health Agenda

After a historic UN meeting, global efforts must be coordinated against noncommunicable diseases to thwart the world’s leading causes of death and disability.

Written byEdward E. Partridge, Elizabeth J. Mayer-Davis, and Ralph L. Sacco
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

WIKIMEDIA COMMONS, JOSEPH SCOZZARI

Last month (September 19-20), the General Assembly of the United Nations held a historic High-Level Meeting to discuss noncommunicable diseases (NCDs), an often overlooked burden on the world’s populations and economies. Only the second of its kind for a public health issue, the meeting was an unparalleled opportunity to put NCDs—including cancer, diabetes, cardiovascular disease, stroke, and chronic respiratory disease—on the global health agenda. The successful meeting drew an impressive 34 heads of state, and member states unanimously adopted a political declaration that included important language to accelerate effective programs and resources to address NCDs.

NCDs are the most frequent causes of death in every region of the world except Africa, accounting for about 63 percent of global deaths in 2008. The total number of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies